Galapagos NV
GLPG
#4575
Rank
โ‚ฌ1.81 B
Marketcap
27,57ย โ‚ฌ
Share price
0.37%
Change (1 day)
6.18%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚ฌ1.81 Billion

As of December 2025 Galapagos NV has a market cap of โ‚ฌ1.81 Billion. This makes Galapagos NV the world's 4575th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ1.81 B5.09%
2024โ‚ฌ1.72 B-28.66%
2023โ‚ฌ2.42 B-11.04%
2022โ‚ฌ2.72 B-15.56%
2021โ‚ฌ3.22 B-38.72%
2020โ‚ฌ5.26 B-56.35%
2019โ‚ฌ12.05 B174.87%
2018โ‚ฌ4.38 B9.61%
2017โ‚ฌ4.00 B41.28%
2016โ‚ฌ2.83 B25.66%
2015โ‚ฌ2.25 B380.44%
2014โ‚ฌ0.46 B3.4%
2013โ‚ฌ0.45 B6.23%
2012โ‚ฌ0.42 B55.55%
2011โ‚ฌ0.27 B-14.13%
2010โ‚ฌ0.31 B79.77%
2009โ‚ฌ0.17 B142.03%
2008โ‚ฌ73.5 M

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Galapagos NV was reported to be:

โ‚ฌ1.81 Billion
by Nasdaq info icon info icon
โ‚ฌ1.81 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
โ‚ฌ240.93 B 13,162.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚ฌ423.97 B 23,237.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ99.51 B 5,377.53%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚ฌ341.90 B 18,719.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚ฌ95.36 M-94.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ184.95 B 10,080.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ30.39 B 1,572.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ83.46 B 4,494.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ222.01 B 12,120.87%๐Ÿ‡บ๐Ÿ‡ธ USA